Citigroup Inc Paragon 28, Inc. Transaction History

Citigroup Inc

$163 Billion
Q4 2024

A detailed history of Citigroup Inc transactions in Paragon 28, Inc. stock. As of the latest transaction made, Citigroup Inc holds 39,682 shares of FNA stock, worth $516,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,682

Previous 34,131 16.26%

Holding current value

$516,659

Previous $227,000 80.18%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$4.78 - $10.74 $26,533 - $59,617	5,551 Added 16.26%	39,682 $409,000
Q3 2024 Nov 12, 2024	BUY	$6.32 - $9.03 $150,915 - $215,627	23,879 Added 232.92%	34,131 $227,000
Q2 2024 Aug 12, 2024	BUY	$5.71 - $12.06 $17,095 - $36,107	2,994 Added 41.25%	10,252 $70,000
Q1 2024 May 10, 2024	BUY	$8.87 - $14.55 $8,905 - $14,608	1,004 Added 16.05%	7,258 $89,000
Q4 2023 Feb 09, 2024	BUY	$8.16 - $13.13 $50,314 - $80,959	6,166 Added 7006.82%	6,254 $77,000
Q3 2023 Nov 09, 2023	SELL	$12.15 - $18.33 $286,885 - $432,807	-23,612 Reduced 99.63%	88 $1,000
Q2 2023 Aug 10, 2023	BUY	$16.64 - $18.88 $366,712 - $416,077	22,038 Added 1325.99%	23,700 $420,000
Q1 2023 May 11, 2023	SELL	$15.89 - $21.05 $4,846 - $6,420	-305 Reduced 15.51%	1,662 $28,000
Q4 2022 Feb 09, 2023	SELL	$16.2 - $21.11 $9,460 - $12,328	-584 Reduced 22.89%	1,967 $37,000
Q3 2022 Nov 10, 2022	SELL	$16.05 - $20.6 $31,907 - $40,952	-1,988 Reduced 43.8%	2,551 $45,000
Q2 2022 Aug 10, 2022	BUY	$12.76 - $19.97 $53,592 - $83,874	4,200 Added 1238.94%	4,539 $72,000
Q1 2022 May 12, 2022	SELL	$13.91 - $18.98 $28,571 - $38,984	-2,054 Reduced 85.83%	339 $6,000
Q4 2021 Feb 10, 2022	BUY	$13.33 - $25.09 $31,898 - $60,040	2,393 New	2,393 $42,000

Others Institutions Holding FNA

# of Institutions

133

Shares Held

48.6M

Call Options Held

12.2K

Put Options Held

1.3K

View Full List

About Paragon 28, Inc.

Ticker FNA
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 76,775,800
Market Cap $1B
Description
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navic...

More about FNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account